Tumor-reactive T helper cells in the context of vaccination against glioma

被引：3

作者：

Zhao, Binghao ^{[1
,2
,5
]}

Kilian, Michael ^{[1
,2
,5
]}

Bunse, Theresa ^{[1
,2
,5
]}

Platten, Michael ^{[1
,2
,3
,4
,5
,6
,7
]}

Bunse, Lukas ^{[1
,2
,3
,5
]}

机构：

[1] German Canc Res Ctr, CCU Neuroimmunol & Brain Tumor Immunol, Heidelberg, Germany

[2] Heidelberg Univ, Med Fac Mannheim, Mannheim Ctr Translat Neurosci, Dept Neurol, Mannheim, Germany

[3] Univ Med Ctr Mannheim, DKFZ Hector Canc Inst, Mannheim, Germany

[4] DKFZ, Helmholtz Inst Translat Oncol Mainz Hitron Mainz H, Mainz, Germany

[5] German Canc Consortium DKTK, DKFZ, Core Ctr, Heidelberg, Germany

[6] DKFZ, Natl Ctr Tumor Dis NCT, Immune Monitoring Unit, Heidelberg, Germany

[7] Univ Hosp, Natl Ctr Tumor Dis NCT, Immune Monitoring Unit, Heidelberg, Germany

来源：

CANCER CELL | 2023年 / 41卷 / 11期

关键词：

D O I：

10.1016/j.ccell.2023.09.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

With the advances in immunogenomics, the majority of tumor-specific antigens were found to be recognized by T helper cells (THCs). This observation led to the development of long epitope vaccines in various cancers. Mechanistically, we are still gaining a deeper understanding of the mode of action of THCs as precision anti-tumor agonists. Here, we discuss the specific cellular mechanisms of THC functions in glioma immunology and contextualize current advances in anti-glioma vaccination exploiting THCs.

引用

页码：1829 / 1834

页数：6

共 50 条

[1] ACTIVATION OF TUMOR-REACTIVE T CELLS AGAINST BRAIN STEM GLIOMA USING HEMATOPOIETIC STEM CELLS
Flores, Catherine
Woodworth, Delaney
Moorley, Cameron
Moore, Ginger
Mitchell, Duane
NEURO-ONCOLOGY, 2018, 20 : 207 - 207
[2] Tumor-reactive CD4+ T cells: plasticity beyond helper and regulatory activities
Quezada, Sergio A.
Peggs, Karl S.
IMMUNOTHERAPY, 2011, 3 (08) : 915 - 917
[3] Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
Dosset, Magalie
Vauchy, Charline
Beziaud, Laurent
Adotevi, Olivier
Godet, Yann
ONCOIMMUNOLOGY, 2013, 2 (03)
[4] Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function
Giuntoli, RL
Lu, J
Kobayashi, H
Kennedy, R
Celis, E
CLINICAL CANCER RESEARCH, 2002, 8 (03) : 922 - 931
[5] Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor
Marcu-Malina, Victoria
Heijhuurs, Sabine
van Buuren, Marit
Hartkamp, Linda
Strand, Susanne
Sebestyen, Zsolt
Scholten, Kirsten
Martens, Anton
Kuball, Juergen
BLOOD, 2011, 118 (01) : 50 - 59
[6] Studying Tumor-ReacTive T Cells: A Personalized Organoid Model
Sahin, Ugur
CELL STEM CELL, 2018, 23 (03) : 318 - 319
[7] Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine
Adotevi, Olivier
Dosset, Magalie
Galaine, Jeanne
Beziaud, Laurent
Godet, Yann
Borg, Christophe
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (05) : 1073 - 1077
[8] Adoptive immunotherapy with hyper-expanded tumor-reactive T cells
Plautz, G
Wang, LX
Shu, SY
JOURNAL OF IMMUNOTHERAPY, 2003, 26 (06): : S24 - S25
[9] Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer
Meng, Qingda
Liu, Zhenjiang
Rangelova, Elena
Poiret, Thomas
Ambati, Aditya
Rane, Lalit
Xie, Shanshan
Verbeke, Caroline
Dodoo, Ernest
Del Chiaro, Marco
Lohr, Matthias
Segersvard, Ralf
Maeurer, Markus J.
JOURNAL OF IMMUNOTHERAPY, 2016, 39 (02) : 81 - 89
[10] Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells
Peng, LM
Shu, SY
Krauss, JC
CANCER RESEARCH, 1997, 57 (21) : 4849 - 4854

← 1 2 3 4 5 →